EW logo

Edwards Lifesciences (EW) EBIT

annual EBIT:

$1.48B-$135.60M(-8.39%)
December 31, 2024

Summary

  • As of today (June 22, 2025), EW annual earnings before interest & taxes is $1.48 billion, with the most recent change of -$135.60 million (-8.39%) on December 31, 2024.
  • During the last 3 years, EW annual EBIT has fallen by -$240.30 million (-13.97%).
  • EW annual EBIT is now -17.16% below its all-time high of $1.79 billion, reached on December 31, 2022.

Performance

EW EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

quarterly EBIT:

$409.90M-$31.20M(-7.07%)
March 1, 2025

Summary

  • As of today (June 22, 2025), EW quarterly earnings before interest & taxes is $409.90 million, with the most recent change of -$31.20 million (-7.07%) on March 1, 2025.
  • Over the past year, EW quarterly EBIT has dropped by -$27.80 million (-6.35%).
  • EW quarterly EBIT is now -49.95% below its all-time high of $818.90 million, reached on December 31, 2014.

Performance

EW quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

TTM EBIT:

$1.62B-$27.80M(-1.68%)
March 1, 2025

Summary

  • As of today (June 22, 2025), EW TTM earnings before interest & taxes is $1.62 billion, with the most recent change of -$27.80 million (-1.68%) on March 1, 2025.
  • Over the past year, EW TTM EBIT has increased by +$171.70 million (+11.83%).
  • EW TTM EBIT is now -11.77% below its all-time high of $1.84 billion, reached on September 30, 2022.

Performance

EW TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

EW EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.4%-6.3%+11.8%
3 y3 years-14.0%-7.5%-8.8%
5 y5 years+24.7%+11.3%+30.2%

EW EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-17.2%at low-9.8%+108.4%-11.8%+17.4%
5 y5-year-17.2%+58.7%-17.5%+1890.0%-11.8%+74.0%
alltimeall time-17.2%+6041.5%-50.0%+869.0%-11.8%+6632.4%

EW EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$409.90M(-7.1%)
$1.62B(-1.7%)
Dec 2024
$1.48B(-8.4%)
$441.10M(+11.9%)
$1.65B(+12.3%)
Sep 2024
-
$394.30M(+4.5%)
$1.47B(+1.8%)
Jun 2024
-
$377.20M(-13.8%)
$1.44B(-0.5%)
Mar 2024
-
$437.70M(+68.0%)
$1.45B(+0.4%)
Dec 2023
$1.62B(-9.6%)
$260.50M(-29.2%)
$1.45B(+4.6%)
Sep 2023
-
$368.10M(-4.3%)
$1.38B(-5.9%)
Jun 2023
-
$384.50M(-11.1%)
$1.47B(-3.9%)
Mar 2023
-
$432.60M(+119.9%)
$1.53B(-0.7%)
Dec 2022
$1.79B(+3.8%)
$196.70M(-56.7%)
$1.54B(-16.3%)
Sep 2022
-
$454.30M(+2.2%)
$1.84B(+3.3%)
Jun 2022
-
$444.70M(+0.4%)
$1.78B(+0.2%)
Mar 2022
-
$443.00M(-10.9%)
$1.78B(+3.3%)
Dec 2021
$1.72B(+84.5%)
$497.00M(+25.5%)
$1.72B(+43.3%)
Sep 2021
-
$396.10M(-10.4%)
$1.20B(+3.3%)
Jun 2021
-
$441.90M(+14.7%)
$1.16B(+22.3%)
Mar 2021
-
$385.40M(-1783.0%)
$949.50M(+1.8%)
Dec 2020
$932.50M(-21.5%)
-$22.90M(-106.4%)
$932.50M(-25.4%)
Sep 2020
-
$357.20M(+55.4%)
$1.25B(+4.8%)
Jun 2020
-
$229.80M(-37.6%)
$1.19B(-4.2%)
Mar 2020
-
$368.40M(+24.8%)
$1.25B(+5.0%)
Dec 2019
$1.19B(+50.0%)
$295.30M(-1.5%)
$1.19B(+31.6%)
Sep 2019
-
$299.90M(+6.2%)
$902.30M(+5.8%)
Jun 2019
-
$282.50M(-8.7%)
$852.80M(+1.7%)
Mar 2019
-
$309.50M(+2876.0%)
$838.80M(+6.0%)
Dec 2018
$791.30M(-25.2%)
$10.40M(-95.8%)
$791.30M(-25.1%)
Sep 2018
-
$250.40M(-6.7%)
$1.06B(+2.9%)
Jun 2018
-
$268.50M(+2.5%)
$1.03B(+1.7%)
Mar 2018
-
$262.00M(-5.1%)
$1.01B(-4.5%)
Dec 2017
$1.06B(+39.8%)
$276.00M(+25.1%)
$1.06B(+10.2%)
Sep 2017
-
$220.70M(-12.4%)
$960.30M(+2.7%)
Jun 2017
-
$251.80M(-18.7%)
$935.00M(+8.2%)
Mar 2017
-
$309.60M(+73.7%)
$864.20M(+14.1%)
Dec 2016
$757.10M(+18.4%)
$178.20M(-8.8%)
$757.10M(+0.9%)
Sep 2016
-
$195.40M(+8.0%)
$750.50M(+5.6%)
Jun 2016
-
$181.00M(-10.6%)
$710.90M(+5.1%)
Mar 2016
-
$202.50M(+18.0%)
$676.70M(+5.8%)
Dec 2015
$639.60M(-44.9%)
$171.60M(+10.1%)
$639.60M(-50.3%)
Sep 2015
-
$155.80M(+6.1%)
$1.29B(+2.1%)
Jun 2015
-
$146.80M(-11.2%)
$1.26B(+2.2%)
Mar 2015
-
$165.40M(-79.8%)
$1.23B(+6.2%)
Dec 2014
$1.16B(+122.9%)
$818.90M(+532.4%)
$1.16B(+124.3%)
Sep 2014
-
$129.50M(+8.5%)
$517.80M(+4.9%)
Jun 2014
-
$119.30M(+27.6%)
$493.80M(-1.4%)
Mar 2014
-
$93.50M(-46.7%)
$501.00M(-3.8%)
Dec 2013
$521.00M(+32.7%)
$175.50M(+66.4%)
$521.00M(+11.8%)
Sep 2013
-
$105.50M(-16.6%)
$466.00M(+2.5%)
Jun 2013
-
$126.50M(+11.5%)
$454.80M(+8.4%)
Mar 2013
-
$113.50M(-5.8%)
$419.40M(+7.0%)
Dec 2012
$392.60M
$120.50M(+27.8%)
$392.00M(+15.0%)
Sep 2012
-
$94.30M(+3.5%)
$341.00M(+11.7%)
DateAnnualQuarterlyTTM
Jun 2012
-
$91.10M(+5.8%)
$305.30M(+6.1%)
Mar 2012
-
$86.10M(+23.9%)
$287.70M(+0.3%)
Dec 2011
$286.70M(+5.9%)
$69.50M(+18.6%)
$286.70M(-0.4%)
Sep 2011
-
$58.60M(-20.3%)
$287.80M(-2.8%)
Jun 2011
-
$73.50M(-13.6%)
$296.10M(+2.2%)
Mar 2011
-
$85.10M(+20.5%)
$289.70M(+7.1%)
Dec 2010
$270.60M(-11.9%)
$70.60M(+5.5%)
$270.40M(+2.9%)
Sep 2010
-
$66.90M(-0.3%)
$262.70M(-9.7%)
Jun 2010
-
$67.10M(+2.0%)
$290.90M(+1.3%)
Mar 2010
-
$65.80M(+4.6%)
$287.10M(-6.5%)
Dec 2009
$307.10M(+79.0%)
$62.90M(-33.9%)
$307.10M(+12.7%)
Sep 2009
-
$95.10M(+50.2%)
$272.40M(+22.9%)
Jun 2009
-
$63.30M(-26.2%)
$221.60M(+4.4%)
Mar 2009
-
$85.80M(+204.3%)
$212.30M(+30.0%)
Dec 2008
$171.60M(-0.6%)
$28.20M(-36.3%)
$163.30M(-9.5%)
Sep 2008
-
$44.30M(-18.0%)
$180.50M(+4.5%)
Jun 2008
-
$54.00M(+46.7%)
$172.80M(+4.2%)
Mar 2008
-
$36.80M(-18.9%)
$165.90M(-4.5%)
Dec 2007
$172.60M(-0.3%)
$45.40M(+24.0%)
$173.70M(+1.3%)
Sep 2007
-
$36.60M(-22.3%)
$171.40M(-2.1%)
Jun 2007
-
$47.10M(+5.6%)
$175.00M(+0.8%)
Mar 2007
-
$44.60M(+3.5%)
$173.60M(-11.0%)
Dec 2006
$173.20M(-1.2%)
$43.10M(+7.2%)
$195.00M(-1.9%)
Sep 2006
-
$40.20M(-12.0%)
$198.80M(+0.1%)
Jun 2006
-
$45.70M(-30.8%)
$198.70M(-0.2%)
Mar 2006
-
$66.00M(+40.7%)
$199.00M(+13.3%)
Dec 2005
$175.30M(+13.5%)
$46.90M(+17.0%)
$175.60M(+4.2%)
Sep 2005
-
$40.10M(-12.8%)
$168.50M(+2.9%)
Jun 2005
-
$46.00M(+8.0%)
$163.70M(+3.5%)
Mar 2005
-
$42.60M(+7.0%)
$158.20M(+13.8%)
Dec 2004
$154.40M(+11.6%)
$39.80M(+12.7%)
$139.00M(+0.5%)
Sep 2004
-
$35.30M(-12.8%)
$138.30M(+2.5%)
Jun 2004
-
$40.50M(+73.1%)
$134.90M(+7.5%)
Mar 2004
-
$23.40M(-40.2%)
$125.50M(-7.1%)
Dec 2003
$138.40M(+165.6%)
$39.10M(+22.6%)
$135.10M(+6.4%)
Sep 2003
-
$31.90M(+2.6%)
$127.00M(+134.3%)
Jun 2003
-
$31.10M(-5.8%)
$54.20M(0.0%)
Mar 2003
-
$33.00M(+6.5%)
$54.20M(+4.0%)
Dec 2002
$52.10M(+116.2%)
$31.00M(-175.8%)
$52.10M(+8.1%)
Sep 2002
-
-$40.90M(-231.5%)
$48.20M(-57.1%)
Jun 2002
-
$31.10M(+0.6%)
$112.40M(+301.4%)
Mar 2002
-
$30.90M(+14.0%)
$28.00M(+16.2%)
Dec 2001
$24.10M(-74.6%)
$27.10M(+16.3%)
$24.10M(-44.0%)
Sep 2001
-
$23.30M(-143.7%)
$43.00M(-2.3%)
Jun 2001
-
-$53.30M(-297.4%)
$44.00M(-58.2%)
Mar 2001
-
$27.00M(-41.3%)
$105.30M(+1.9%)
Dec 2000
$95.00M(-18.8%)
$46.00M(+89.3%)
$103.30M(+80.3%)
Sep 2000
-
$24.30M(+203.8%)
$57.30M(+73.6%)
Jun 2000
-
$8.00M(-68.0%)
$33.00M(+32.0%)
Mar 2000
-
$25.00M
$25.00M
Dec 1999
$117.00M
-
-

FAQ

  • What is Edwards Lifesciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Edwards Lifesciences?
  • What is Edwards Lifesciences annual EBIT year-on-year change?
  • What is Edwards Lifesciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly EBIT year-on-year change?
  • What is Edwards Lifesciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Edwards Lifesciences?
  • What is Edwards Lifesciences TTM EBIT year-on-year change?

What is Edwards Lifesciences annual earnings before interest & taxes?

The current annual EBIT of EW is $1.48B

What is the all time high annual EBIT for Edwards Lifesciences?

Edwards Lifesciences all-time high annual earnings before interest & taxes is $1.79B

What is Edwards Lifesciences annual EBIT year-on-year change?

Over the past year, EW annual earnings before interest & taxes has changed by -$135.60M (-8.39%)

What is Edwards Lifesciences quarterly earnings before interest & taxes?

The current quarterly EBIT of EW is $409.90M

What is the all time high quarterly EBIT for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly earnings before interest & taxes is $818.90M

What is Edwards Lifesciences quarterly EBIT year-on-year change?

Over the past year, EW quarterly earnings before interest & taxes has changed by -$27.80M (-6.35%)

What is Edwards Lifesciences TTM earnings before interest & taxes?

The current TTM EBIT of EW is $1.62B

What is the all time high TTM EBIT for Edwards Lifesciences?

Edwards Lifesciences all-time high TTM earnings before interest & taxes is $1.84B

What is Edwards Lifesciences TTM EBIT year-on-year change?

Over the past year, EW TTM earnings before interest & taxes has changed by +$171.70M (+11.83%)
On this page